Published by Josh White on 22nd January 2021
(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced preclinical data demonstrating that 'SFX-01' is an inhibitor of SHP2 on Friday.
URL: http://www.digitallook.com/dl/news/story/31595728/...